An in vitro model for long-term hepatotoxicity testing utilizing rat hepatocytes entrapped in micro-hollow fiber reactor

Biochemical Engineering Journal

Volumn 34, Issue 3, 2007, Pages 267-272

  Shen, Chong ^a   Zhang, Guoliang ^b   Meng, Qin ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Hepatocyte monolayer; Micro hollow fiber reactor; Rat hepatocytes

Indexed keywords

BIODIVERSITY; CHEMICAL REACTORS; ENZYMES; LIVING SYSTEMS STUDIES; METABOLISM; MOLECULAR WEIGHT; MONOLAYERS;

CHRONIC HEPATOTOXICITY; HEPATOCYTE MONOLAYERS; MICRO-HOLLOW FIBER REACTORS; RAT HEPATOCYTES;

TOXICITY;

DRUG METABOLIZING ENZYME; ISONIAZID; PARACETAMOL; POLYSULFONE; RIFAMPICIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CULTURE; HOLLOW FIBER; HOLLOW FIBER REACTOR; IN VITRO STUDY; LIVER CELL; LIVER FUNCTION; LIVER TOXICITY; MOLECULAR WEIGHT; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; RESEARCH; TOXICITY TESTING;

RATTUS;

EID: 33947597840     PISSN: 1369703X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bej.2006.12.010     Document Type: Article

References (33)

1. Viau C.J., Curren R.D., and Wallace K. Cytotoxicity of tacrine and velnacrine metabolites in cultured rat, dog and human hepatocytes. Drug Chem. Toxicol. 16 3 (1993) 227-239
2. Harauchi T., and Hirata M. Effect of P-450 inducers on glutathione (GSH) depletion by bromobenzene in primary cultures of dog hepatocytes. Biol. Pharm. Bull. 17 5 (1994) 658-661
3. Lagadic-Gossmann D., Rissel M., Le Bot M.A., and Guillouzo A. Toxic effects of tacrine on primary hepatocytes and liver epithelial cells in culture. Cell Biol. Toxicol. 14 5 (1998) 361-373
4. Brandon E.F., Raap C.D., Meijerman I., Beijnen J.H., and Schellens J.H. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol. Appl. Pharmacol. 189 3 (2003) 233-246
5. Bhadriraju K., and Chen C.S. Engineering cellular microenvironments to improve cell-based drug testing. Drug Discov. Today 7 11 (2002) 612-620
6. Walker T.M., Rhodes P.C., and Westmoreland C. The differential cytotoxicity of methotrexate in rat hepatocyte monolayer and spheroid cultures. Toxicol. In Vitro 14 5 (2000) 475-485
7. Tong J.Z., De Lagausie P., Furlan V., Cresteil T., Bernard O., and Alvarez F. Long-term culture of adult rat hepatocyte spheroids. Exp. Cell Res. 200 2 (1992) 326-332
8. Beken S., Vanhaecke T., De Smet K., Pauwels M., Vercruysse A., and Rogiers V. Collagen-gel cultures of rat hepatocytes: collagen-gel sandwich and immobilization cultures. Meth. Mol. Biol. 107 (1998) 303-309
9. Walker T.M., and Woodrooffe A.J. Cytochrome P450 activity in control and induced long-term cultures of rat hepatocyte spheroids. Toxicol. In Vitro 15 6 (2001) 713-719
10. Berthiaume F., Moghe P.V., Toner M., and Yarmush M.L. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration. FASEB J. 10 13 (1996) 1471-1484
11. Farkas D., and Tannenbaum S.R. Characterization of chemically induced hepatotoxicity in collagen sandwiches of rat hepatocytes. Toxicol. Sci. 85 2 (2005) 927-934
12. Dunn J.C., Tompkins R.G., and Yarmush M.L. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol. Prog. 7 3 (1991) 237-245
13. Gebhardt R., Hengstler J.G., Muller D., Glockner R., Buenning P., Laube B., Schmelzer E., Ullrich M., Utesch D., Hewitt N., Ringel M., Hilz B.R., Bader A., Langsch A., Koose T., Burger H.J., Maas J., and Oesch F. New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab. Rev. 35 2-3 (2003) 145-213
14. Ringel M., von Mach M.A., Santos R., Feilen P.J., Brulport M., Hermes M., Bauer A.W., Schormann W., Tanner B., Schon M.R., Oesch F., and Hengstler J.G. Hepatocytes cultured in alginate microspheres: an optimized technique to study enzyme induction. Toxicology 206 1 (2005) 153-167
15. Sielaff T.D., Nyberg S.L., Rollins M.D., Hu M.Y., Amiot B., Lee A., Wu F.J., Hu W.S., and Cerra F.B. Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver. Cell Biol. Toxicol. 13 4-5 (1997) 357-364
16. Wu D.Q., Zhang G.L., Shen C., Zhao Q., Li H., and Meng Q. Evaluation of diffusion in gel entrapment cell culture within hollow fibers. World J. Gastroenterol. 11 11 (2005) 1599-1604
17. Wang H.Z., Chang C.H., Lin C.P., and Tsai M.C. Using MTT viability assay to test the cytotoxicity of antibiotics and steroid to cultured porcine corneal endothelial cells. J. Ocul. Pharmacol. Ther. 12 1 (1996) 35-43
18. Abu-Absi S.F., Seth G., Narayanan R.A., Groehler K., Lai P., Anderson M.L., Sielaff T., and Hu W.S. Characterization of a hollow fiber bioartificial liver device. Artif. Organs 29 5 (2005) 419-422
19. Nyberg S.L., Shirabe K., Peshwa M.V., Sielaff T.D., Crotty P.L., Mann H.J., Remmel R.P., Payne W.D., Hu W.S., and Cerra F.B. Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions. Cell Transplant. 2 6 (1993) 441-452
20. Qiu H.X., Su G.G., Tang X., and Meng Q. Tissue-like cultures of rat hepatocytes in study of phase I and phase II drug metabolism. J. Zhejiang Univ. Med. Sci. 35 5 (2006) 541-546
21. Cheung C., Yu A.M., Ward J.M., Krausz K.W., Akiyama T.E., Feigenbaum L., and Gonzalez F.J. The cyp2e1-humanized transgenic mouse: role of cyp2e1 in acetaminophen hepatotoxicity. Drug Metab. Dispos. 33 3 (2005) 449-457
22. Jones B.E., Liu H., Lo C.R., Koop D.R., and Czaja M.J. Cytochrome P450 2E1 expression induces hepatocyte resistance to cell death from oxidative stress. Antioxid. Redox. Signal. 4 5 (2002) 701-709
23. Bajt M.L., Knight T.R., Lemasters J.J., and Jaeschke H. Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicol. Sci. 80 2 (2004) 343-349
24. Tran A., Treluyer J.M., Rey E., Barbet J., Ferracci G., d'Athis P., Vincent J., and Pons G. Protective effect of stiripentol on acetaminophen-induced hepatotoxicity in rat. Toxicol. Appl. Pharmacol. 170 3 (2001) 145-152
25. Farkas D., and Tannenbaum S.R. Characterization of chemically induced hepatotoxicity in collagen sandwiches of rat hepatocytes. Toxicol. Sci. 85 2 (2005) 927-934
26. Xu J., and Purcell W.M. Energy metabolism and biotransformation as endpoints to pre-screen hepatotoxicity using a liver spheroid model. Toxicol. Appl. Pharmacol. 216 2 (2006) 293-302
27. Yew W.W. Clinically significant interactions with drugs used in the treatment of tuberculosis. Drug Saf. 25 2 (2002) 111-133
28. Karthikeyan S. Isoniazid and rifampicin treatment on phospholipids and their subfractions in liver tissue of rabbits. Drug Chem. Toxicol. 28 3 (2005) 273-280
29. Girling D.J. The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide. Tubercle 59 1 (1978) 13-32
30. Attri S., Rana S.V., Vaiphei K., Sodhi C.P., Katyal R., Goel R.C., Nain C.K., and Singh K. Isoniazid- and rifampicin-induced oxidative hepatic injury-protection by N-acetylcysteine. Hum. Exp. Toxicol. 19 9 (2000) 517-522
31. Agrawal S., Singh I., Kaur K.J., Bhade S.R., Kaul C.L., and Panchagnula R. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels. Int. J. Pharm. 276 1-2 (2004) 41-49
32. Dilworth C., Hamilton G.A., George E., and Timbrell J.A. The use of liver spheroids as an in vitro model for studying induction of the stress response as a marker of chemical toxicity. Toxicol. In Vitro 14 2 (2000) 169-176
33. Battle T., Maguire T., Moulsdale H., and Doyle A. Progressive maturation resistance to microcystin-LR cytotoxicity in two different hepatospheroidal models. Cell Biol. Toxicol. 15 1 (1999) 3-12